STMH Stock Overview
Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company.
Stem Holdings, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.019|
|52 Week High||US$0.16|
|52 Week Low||US$0.017|
|1 Month Change||-36.61%|
|3 Month Change||-45.48%|
|1 Year Change||-86.74%|
|3 Year Change||-97.91%|
|5 Year Change||n/a|
|Change since IPO||-99.53%|
Recent News & Updates
|STMH||US Pharmaceuticals||US Market|
Return vs Industry: STMH underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.
Return vs Market: STMH underperformed the US Market which returned -18.5% over the past year.
|STMH Average Weekly Movement||27.0%|
|Pharmaceuticals Industry Average Movement||10.8%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: STMH is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 27% a week.
Volatility Over Time: STMH's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company. It engages in the production, distribution, and sale of cannabis and cannabis-infused products. The company’s brands include TJ’s Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavore edible confections; Doseology, a CBD mass-market brand; and delivery-as-a-service brands of Budee and Ganjarunner e-commerce platforms.
Stem Holdings, Inc. Fundamentals Summary
|STMH fundamental statistics|
Is STMH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|STMH income statement (TTM)|
|Cost of Revenue||US$27.91m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.28|
|Net Profit Margin||-195.87%|
How did STMH perform over the long term?See historical performance and comparison